31 /100
MEDIUM RISK
Score updated Jul 13, 2026

NROM — Noble Roman's, Inc. Dilution Risk Tracker

Track NROM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NROM — Get alerts when the score changes →

As of July 13, 2026, Noble Roman's, Inc. (NROM) has a DilutionWatch DilutionScore of 31/100, rated MEDIUM dilution risk. Noble Roman's, Inc. has a market capitalization of $7.11M, 22.22M shares outstanding. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
17
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
46%
🔁 Convertible Conversion 60%
• Major convertible overhang: 30% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split 55%
• 50-day avg $0.31 below $1 exchange minimum
🔔 Track NROM — Get forecast alerts →

💹 Market Data

Market Cap$7.11M
Shares Outstanding22.22M
Float17.82M
Cash$551.5K
Debt$10.01M
Short InterestN/A

🏛 Institutional Holdings

Institutional data not yet available.

📉 Short Interest

Short Interest50.3K
Days to Cover1.0
% of Float0.3%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for NROM Shareholders

Noble Roman's, Inc. (NROM) has a DilutionScore of 31/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for NROM shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for NROM in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for NROM alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track NROM Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NROM — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for NROM
📊 NROM FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NROM Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.